Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Chumming Away …
View:
Post by Mole101 on Aug 26, 2021 3:48pm

Chumming Away …

As expected Anon is the big seller but nice to see strong house buying...

 
From:  To:  

1,010,827 ($205,699) PMN.TO shares exchanged hands today.
House  Bought  Sold  Net 
House 089
Raymond James
Bought $44,053
Volume 213,512
Average $0.206
Sold 0
Volume 0
Average 0
Net $44,053
Volume 213,512
 
House 068
Leede
Bought $31,800
Volume 159,000
Average $0.200
Sold 0
Volume 0
Average 0
Net $31,800
Volume 159,000
 
House 085
Scotia
Bought $30,400
Volume 152,000
Average $0.200
Sold 0
Volume 0
Average 0
Net $30,400
Volume 152,000
 
House 079
CIBC
Bought $26,413
Volume 128,175
Average $0.206
Sold $134
Volume 640
Average $0.209
Net $26,279
Volume 127,535
 
House 022
Fidelity
Bought $18,552
Volume 90,500
Average $0.205
Sold 0
Volume 0
Average 0
Net $18,552
Volume 90,500
 
House 053
Morgan Stanley
Bought $18,180
Volume 90,000
Average $0.202
Sold $102
Volume 500
Average $0.204
Net $18,078
Volume 89,500
 
House 088
Credential
Bought $12,300
Volume 60,000
Average $0.205
Sold 0
Volume 0
Average 0
Net $12,300
Volume 60,000
 
House 013
Instinet
Bought $11,112
Volume 55,000
Average $0.202
Sold $4,100
Volume 20,000
Average $0.205

 
From:  To:  
House 001
Anonymous
Bought $12,735
Volume 62,000
Average $0.205
Sold $186,422
Volume 916,012
Average $0.204
Net $-173,687
Volume -85

 


1,010,827 ($205,699) PMN.TO shares exchanged hands today.

House  Bought  Sold  Net 
House 089
Raymond James
Bought $44,053
Volume 213,512
Average $0.206
Sold 0
Volume 0
Average 0
Net $44,053
Volume 213,512
 
House 068
Leede
Bought $31,800
Volume 159,000
Average $0.200
Sold 0
Volume 0
Average 0
Net $31,800
Volume 159,000
 
House 085
Scotia
Bought $30,400
Volume 152,000
Average $0.200
Sold 0
Volume 0
Average 0
Net $30,400
Volume 152,000
 
House 079
CIBC
Bought $26,413
Volume 128,175
Average $0.206
Sold $134
Volume 640
Average $0.209
Net $26,279
Volume 127,535
 
House 022
Fidelity
Bought $18,552
Volume 90,500
Average $0.205
Sold 0
Volume 0
Average 0
Net $18,552
Volume 90,500
 
House 053
Morgan Stanley
Bought $18,180
Volume 90,000
Average $0.202
Sold $102
Volume 500
Average $0.204
Net $18,078
Volume 89,500
 
House 088
Credential
Bought $12,300
Volume 60,000
Average $0.205
Sold 0
Volume 0
Average 0
Net $12,300
Volume 60,000
 
House 013
Instinet
Bought $11,112
Volume 55,000
Average $0.202
Sold $4,100
Volume 20,000
Average $0.205
Comment by M101 on Aug 26, 2021 6:37pm
Any trader would be backing off the sell side right now, it makes no sense to continue liquidating unless you have some requirement to hold debt not equity, and that's essentially what the warrant accumulation strategy was.  What we're seeing this week just justifies everything negative said about Golstein's financing strategy. 
Comment by Mole101 on Aug 26, 2021 8:08pm
If you bought last November at .12 and bought again this week at .20 , I think makes perfect sense and as you said they still jold the warrants ..it's a nice way to make easy $$ 80% profit in 9 months isn't bad ..  
ProMIS Neurosciences Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities